Carle Cancer Institute is the premier cancer treatment and support center in east central Illinois, offering more resources to help patients in the fight against cancer. With the area's largest and most specialized team of fellowship trained oncologists, surgeons and staff, patients get in for diagnosis and start treatment as soon as possible. Our team offers the latest technology and highly specialized multidisciplinary clinics for certain cancers, including breast, prostate, gynecologic, and head and neck. But we don't just treat a disease – we care for the whole patient, offering support groups, genetic and nutrition counseling, nurse navigator services and more.
Our experts in oncology, breast imaging, reconstructive surgery, genetics, research and support services, give you the tools you need in the fight against breast cancer.
With a team approach to care, experts at Carle Cancer Institute develop an individualized plan of treatment for patients with gastrointestinal cancer.
Carle gynecologic oncology team serves women who have or are suspected of having ovarian, cervical, endometrial, and vulvar cancers.
The Carle Cancer Institute focuses on aggressive and effective treatment, helping to instill hope in patients undergoing what is often an unknown journey.
With a team approach to care, experts at Carle Cancer Institute develop an individualized plan of treatment for patients with lung cancer.
With a team approach to care, experts at Carle Cancer Center develop an individualized plan of treatment for patients with lymphoma and leukemia.
Experts at Carle Cancer Institute along with Dermatology and Plastic Surgery experts develop and individualized plan for patients with skin cancer.
Our urologic cancer practice is based on a multi-specialty approach that combines clinical expertise from urology and radiation oncology.
Have a patient referral? Refer a patient now.
Involved in national research for more than 30 years, Carle Cancer Institute offers its patients access to innovative ways to fight cancer through clinical trials. Clinical trials offer new insight into how to combat a disease like cancer and demonstrate new ways of preventing, treating, or possibly curing cancer.
Carle Cancer Institute provides access to clinical trials for several types of cancer including but not limited to breast, lung, colon, melanoma, prostate, and ovarian cancer. We are also actively involved in national prevention clinical trials per cancer type. In addition, we offer symptom management program to address the quality of life of cancer patients.
People who have been treated for head and neck cancer (HNC survivors) can experience serious consequences from their cancer and its treatment, ongoing risks of new cancers, and other unrelated illnesses. These concerns pose challenges to the provision of comprehensive care to HNC survivors. We created HN-STAR to facilitate and tailor the ongoing care of HNC survivors. Survivors use HN-STAR on a computer or tablet to answer questions about symptoms and health concerns before a routine visit with a cancer care provider. During the clinic visit, the provider uses HN-STAR to see evidence-based recommendations for managing each concern reported by the survivor. The provider and survivor discuss recommendations and select appropriate actions (e.g., testing, referrals, prescriptions, self-management). HN-STAR produces a survivorship care plan that includes all reported concerns and the actions selected in clinic. The survivorship care plan is given to the survivor and the primary care provider. Three months, six months, and nine months later, the survivor uses HN-STAR from home (or clinic) to report their concerns again, and a new survivorship care plan is created each time. Our trial randomizes =30 oncology practices from the National Community Oncology Research Program to use HN-STAR or provide usual care to 350 recent survivors of head and neck cancer. We hypothesize that survivors in the HN-STAR arm will have greater improvement in patient-centered outcomes (including cancer-related well-being, symptoms, and patient activation) over one year compared to survivors in the usual care arm, measured by surveys at baseline and one year later. We also hypothesize that survivors in the HN-STAR arm will be more likely to receive care that is aligned with evidence-based recommendations during the year of the study than survivors in the usual care arm. Our final aim investigates the implementation of HN-STAR in clinical practice, using interviews and surveys of survivors, providers, and other clinic staff to understand the feasibility, acceptability, appropriateness, and other aspects of providing survivorship care to head and neck cancer survivors.
This study will examine the association between low muscle mass (myopenia) at diagnosis and chemotherapy toxicity in older adults with newly diagnosed advanced colorectal cancer.
To determine whether an Internet-based pain coping skills program plus enhanced usual care, compared to enhanced usual care alone, yields significant improvements in the co-primary outcomes of pain severity (as measured by the Brief Pain Inventory (BPI)) and pain interference (also measured by the BPI) from baseline to the post-intervention assessment for cancer survivors with persistent pain.
With doctors practicing in 80 specialties at locations throughout the region, it’s easy to find the right healthcare team at Carle. Our mission is to serve people through high quality care, medical research and education.
Charitable gifts are used for numerous projects and programs that enhance the healthcare experience for cancer patients and their loved ones. With your support, we’ll continue to work to eliminate cancer through excellence in diagnosis, treatment, research and education.
Recognized among the nation’s top hospitals, Carle provides excellent healthcare while continuously improving to meet the needs of our patients.